Table 1 Demographics and clinical parameters of paediatric lupus patients and control groups
Variables | pSLE (N = 40)1 | Controls (N = 20)1 | p value2 |
|---|---|---|---|
Age (years) | |||
Median | 12 | 13 | 0.213 |
Range | 5-16 | 10-15 | |
Sex (Female/male) | 34/6 | 15/5 | 0.326 |
Disease duration (months) | |||
Median | 8 | NA | |
Range | 1-96 | NA | |
SLEDAI score | |||
Median | 15 | NA | |
Range | 4-26 | ||
Clinical manifestations 1 | |||
Cutaneous | 25 (62.5) | NA | |
Skin Biopsy | 13 (32.5) | NA | |
Renal | 24 (60) | NA | |
Renal Biopsy | 10 (25) | NA | |
Haematological | 18 (45) | NA | |
Oral ulcers | 12 (30) | NA | |
Musculoskeletal | 12 (30) | NA | |
Neurological | 10 (25) | NA | |
Medications used 1 | |||
I. Prednisolone | 11(27.5) | ||
II. Prednisolone and anti-malarials (chloroquine and hydroxychloroquine) | 19 (47.5) | ||
III. Immunosuppressive therapy 3 | 10 (25) | ||